Migraine

SAN DIEGO — For younger people with migraine, lidocaine injections were linked to better outcomes compared with saline injections, according to a speaker at the American Headache Society Annual Scientific Meeting.

SAN DIEGO — Patients with migraine who received daytime psilocybin experienced reduced REM sleep, with effects lasting beyond the day of administration, according to a poster at the American Headache Society Annual Scientific Meeting.

SAN DIEGO — A novel, oral therapeutic for treatment of migraine was safe and well-tolerated in single ascending doses in a cohort of healthy adults, according to a speaker at the American Headache Society Annual Scientific Meeting.

SAN DIEGO – Spontaneous intracranial hypotension led to significant physical, mental and quality of life impact for a cohort of those with the condition, according to a speaker at the American Headache Society Annual Scientific Meeting.

SAN DIEGO — AI-based models are currently best utilized as a predictor of headache, but show promise for expansion into the health care continuum, according to a speaker at the American Headache Society Annual Scientific Meeting.

DENVER — Treatment with 10 mg zavegepant nasal spray was associated with a higher likelihood of pain freedom compared with placebo at 2 hours post dose, according to a presentation at the American Academy of Neurology annual meeting.

There may be a link between chronic kidney disease and the onset of migraines in Korean adults, according to data from a nationwide longitudinal follow-up study.

DENVER — Children from underrepresented groups with migraine received fewer diagnoses, imaging, tests and medication compared with their white counterparts, according to a poster at the American Academy of Neurology annual meeting.

DENVER — The concomitant use of atogepant for preventive and ubrogepant for acute migraine treatment was found to be safe and well-tolerated over 12 weeks, according to research presented at the American Academy of Neurology annual meeting.

DENVER — Among a large cohort of Danish citizens, headache disorders were strongly associated with attempted and completed suicide, according to a presenter at the American Academy of Neurology annual meeting.